Rana Elmaghraby, MD

AACAP Annual Meeting 2026

October 26–31, 2026 · Atlanta, GA · Full program

• SymposiumThe Complex Landscape of Depression in Neurodiverse and Gender-Variant Youth: From Chronology to Novel Interventions

  October 26, 2026, 13:00–15:00

  Symposium on how depression presents and is managed in neurodiverse and gender-variant youth, covering its course over time and newer intervention approaches.

  Autism & Neurodevelopmental DisordersChild & AdolescentDepressionDiverse & Underserved Populations

• LectureAccelerated Theta Burst Stimulation for Treatment-Resistant Depression in ASD: From Open-Label Promise to Randomized Controlled Trial

  October 26, 2026, 13:00–15:00

  A talk within a symposium on depression in neurodiverse and gender-variant youth, covering accelerated theta burst stimulation for treatment-resistant depression in autistic youth, from open-label findings toward a randomized controlled trial.

  Autism & Neurodevelopmental DisordersChild & AdolescentNeuromodulation (ECT, TMS)Treatment-Resistant Depression

• LectureJames C. Harris, MD, Developmental Neuropsychiatry Forum: Translational Frontiers in Autism: Advancing Discovery from Gene Pathways to Patients

  October 27, 2026

  Matthew State presents how the identification of more than 100 high-confidence autism risk genes is being turned into therapeutic programs, with profound autism as a tractable starting point, while Alison Singer brings the family perspective on genetic testing and trial participation.

  Autism & Neurodevelopmental DisordersNeuroscience & MechanismsPharmacogenomics & Precision PsychiatryDrug Pipeline & Clinical Trials

• LectureElectrophysiological Biomarkers and Neuromodulation for Executive-Function Deficits Across Neurodevelopmental Disorders: Innovative Approaches in ASD and Fragile X Syndrome

  October 29, 2026, 11:30–13:30

  Covers electrophysiological biomarkers and neuromodulation approaches targeting executive-function deficits in ASD and Fragile X syndrome.

  Autism & Neurodevelopmental DisordersNeuromodulation (ECT, TMS)Neuroscience & Mechanisms

• LectureAccelerated Theta Burst Stimulation for Treatment-Resistant Depression in ASD: Clinical, Cognitive, and EEG Outcomes From the RESTORE Randomized Controlled Trial

  October 29, 2026, 11:30–13:00

  Randomized trial results on accelerated theta burst stimulation for treatment-resistant depression in autistic patients, covering clinical, cognitive and EEG outcomes.

  Autism & Neurodevelopmental DisordersNeuromodulation (ECT, TMS)Treatment-Resistant Depression

• SymposiumChairInnovations in Brain- and Behavior-Based Biomarkers Across Development: From Early Risk Detection to Treatment Response in Neurodevelopmental Disorders

  October 29, 2026, 11:30–13:30

  Symposium on brain- and behavior-based biomarkers in neurodevelopmental disorders, from early risk detection through treatment response.

  Autism & Neurodevelopmental DisordersChild & AdolescentNeuroscience & MechanismsPharmacogenomics & Precision Psychiatry

• PosterClinician Knowledge and Implementation Barriers to Adolescent Transcranial Magnetic Stimulation ( TMS) After FDA Approval: A Cross‑Sectional Study

  October 29, 2026, 13:00–15:00

  Cross-sectional survey of clinician knowledge and barriers to implementing TMS for adolescents following FDA approval.

  Child & AdolescentNeuromodulation (ECT, TMS)Practice, Policy & Workforce

• WorkshopCreate, Don’t Just Chat: A Full-Day, Hands-On AI Implementation Workshop for Child Psychiatrists

  October 30, 2026

  Full-day hands-on follow-up to two sold-out AACAP AI workshops, moving clinicians from ephemeral chat-based AI use to structured, document-centric workflows that are auditable and practice-ready for administrative and educational tasks.

  Child & AdolescentDigital Psychiatry & AI